3b Blackbio Dx Ltd vs Rainbow Childrens Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1332 as of 23 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Rainbow Childrens Medicare Ltd changed from 35.2 on March 2023 to 42.4 on March 2026 . This represents a CAGR of 4.76% over 4 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Rainbow Childrens Medicare Ltd changed from ₹ 7412 crore on March 2023 to ₹ 11814 crore on March 2026 . This represents a CAGR of 12.36% over 4 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 482.7 crore as compare to the Mar '26 revenue of ₹ 464.97 crore. This represent the growth of 3.81% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 147.36 crore as compare to the Mar '26 ebitda of ₹ 148.23 crore. This represent the decline of -0.59% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Rainbow Childrens Medicare Ltd changed from ₹ 39.73 crore to ₹ 62.54 crore over 9 quarters. This represents a CAGR of 22.34% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Rainbow Childrens Medicare Ltd changed from 13.22 % on March 2022 to 14.22 % on March 2026 . This represents a CAGR of 1.47% over 5 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Rainbow Childrens Medicare Ltd

Rainbow Childrens Medicare Limited was originally incorporated as Rainbow Children's Medicare Private Limited' as Private Company dated August 7, 1998, issued by the Registrar of Companies, Hyderabad at Telangana.
Subsequently, the Company converted into a Public Limited, and name of the Company was changed to Rainbow Children's Medicare Limited' via fresh Certificate Incorporated issued by the RoC on November 20, 2021. The Company is a leading chain of multi-specialty pediatric, and obstetrics & gynecology hospitals in India, operating 19 hospitals and 5 outpatient clinic centers across 6 cities, with a total bed capacity of 1,935 beds, five of which are NABH-accredited and three of which have 183 received EDGE certification.
The core specialties are Pediatrics and Obstetrics & Gynecology and emergency services.

FAQs for the comparison of 3B Blackbio DX Ltd and Rainbow Childrens Medicare Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Rainbow Childrens Medicare Ltd?

Market cap of 3B Blackbio DX Ltd is 1,144 Cr while Market cap of Rainbow Childrens Medicare Ltd is 11,876 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Rainbow Childrens Medicare Ltd?

The stock performance of 3B Blackbio DX Ltd and Rainbow Childrens Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Rainbow Childrens Medicare Ltd?

As of October 25, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1332.95. On the other hand, Rainbow Childrens Medicare Ltd stock price is INR ₹1169.3.

How do dividend payouts of 3B Blackbio DX Ltd and Rainbow Childrens Medicare Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Rainbow Childrens Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.